Cargando…

Immunity and amyloid beta, total tau and neurofilament light chain: Findings from a community‐based cohort study

INTRODUCTION: We investigated how components of immunity relate to biomarkers of Alzheimer's disease (AD) in plasma and explored the influence of AD genetic risk factors in the population‐based Rotterdam Study. METHODS: In 7397 persons, we calculated the granulocyte‐to‐lymphocyte ratio (GLR), p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fani, Lana, Ahmad, Shahzad, Ikram, M. Kamran, Ghanbari, Mohsen, Ikram, M. Arfan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Featured Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048997/ https://www.ncbi.nlm.nih.gov/pubmed/33215849 http://dx.doi.org/10.1002/alz.12212

Ejemplares similares

Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study
por: de Wolf, Frank, et al.
Publicado: (2020)

Herpes simplex virus 1 and the risk of dementia: a population-based study
por: Murphy, Meghan J., et al.
Publicado: (2021)

Detection of Alzheimer's disease amyloid beta 1‐42, p‐tau, and t‐tau assays
por: van Harten, Argonde C., et al.
Publicado: (2021)

Actigraphy‐estimated sleep and 24‐hour activity rhythms and the risk of dementia
por: Lysen, Thom S., et al.
Publicado: (2020)

Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China
por: Jiao, Bin, et al.
Publicado: (2021)

Plasma Amyloid-β, Total Tau, and Neurofilament Light Chain Across the Alzheimer’s Disease Clinical Spectrum: A Population-Based Study
por: Dong, Yi, et al.
Publicado: (2023)

Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease
por: Kang, Min Su, et al.
Publicado: (2020)

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
por: Milà‐Alomà, Marta, et al.
Publicado: (2020)

Distinct effects of beta‐amyloid and tau on cortical thickness in cognitively healthy older adults
por: Harrison, Theresa M., et al.
Publicado: (2020)

Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients
por: De Lorenzo , Rebecca, et al.
Publicado: (2021)

Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies
por: Kmezic, Ivan, et al.
Publicado: (2022)

Linking Plasma Amyloid Beta and Neurofilament Light Chain to Intracortical Myelin Content in Cognitively Normal Older Adults
por: Fernandez-Alvarez, Marina, et al.
Publicado: (2022)

Visit-to-visit blood pressure variability and the risk of stroke in the Netherlands: A population-based cohort study
por: Heshmatollah, Alis, et al.
Publicado: (2022)

Circulating biomarkers of immunity and inflammation, risk of Alzheimer’s disease, and hippocampal volume: a Mendelian randomization study
por: Fani, Lana, et al.
Publicado: (2021)

Tau and neurofilament light‐chain as fluid biomarkers in spinocerebellar ataxia type 3
por: Garcia‐Moreno, Hector, et al.
Publicado: (2022)

Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer's disease
por: Raket, Lars Lau, et al.
Publicado: (2020)

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
por: Batzu, Lucia, et al.
Publicado: (2022)

Plasma tau and neurofilament light chain as biomarkers of Alzheimer's disease and their relation to cognitive functions
por: Abed, Sadiruldeen Sami, et al.
Publicado: (2023)

Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients
por: Huang, Yanlu, et al.
Publicado: (2022)

Neurofilament light chain: defining the analyte
por: Leckey, Claire A., et al.
Publicado: (2022)

Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
por: Moscoso, Alexis, et al.
Publicado: (2021)

NPT088 reduces both amyloid-β and tau pathologies in transgenic mice
por: Levenson, Jonathan M., et al.
Publicado: (2016)

Neurofilament light chain predicts risk of recurrence in cerebral amyloid angiopathy-related intracerebral hemorrhage
por: Cheng, Xin, et al.
Publicado: (2020)

Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease
por: Zerr, Inga, et al.
Publicado: (2021)

Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes
por: Marks, Jordan D., et al.
Publicado: (2021)

Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife
por: Kritikos, Minos, et al.
Publicado: (2020)

Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients
por: Traub, Jan, et al.
Publicado: (2022)

Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials
por: Ferreira, Pamela C.L., et al.
Publicado: (2023)

Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus
por: Braun, Madelene, et al.
Publicado: (2022)

Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid
por: Kasuga, Kensaku, et al.
Publicado: (2022)

Neurofilament light chain in the vitreous humor of the eye
por: Subramanian, Manju L., et al.
Publicado: (2020)

Blood Neurofilament Light Chain: The Neurologist’s Troponin?
por: Thebault, Simon, et al.
Publicado: (2020)

The Evolution of Neurofilament Light Chain in Multiple Sclerosis
por: Ferreira-Atuesta, Carolina, et al.
Publicado: (2021)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

Neurofilament light chain concentration in an aging population
por: Ladang, Aurélie, et al.
Publicado: (2022)

Blood neurofilament light chain in Parkinson’s disease
por: Buhmann, Carsten, et al.
Publicado: (2023)

Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals
por: Lussier, Firoza Z., et al.
Publicado: (2020)

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease
por: Chatterjee, Pratishtha, et al.
Publicado: (2019)

Balance between innate versus adaptive immune system and the risk of dementia: a population-based cohort study
por: van der Willik, Kimberly D., et al.
Publicado: (2019)

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
por: Mattsson, Niklas, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lqfsmt1vufno267bleal68025o